FDA and CMS officials call for support of an FDA proposal to regulate laboratory-developed tests.
Federal Register notice: OMB approves an information collection entitled Institutional Review Board Waiver or Alteration of Informed Consent for Minim...
Two Axinn attorneys say there will be a flood of cases challenging federal agency decisions and interpretations of law if the Supreme Court restricts ...
The CDRH 2023 annual report says the Center approved the most novel devices in its history.
Canada health minister Mark Holland says he has been assured by top U.S. officials that the U.S. does not intend to harm Canadas drug supply by approv...
CDRH Office of In Vitro Diagnostics director Timothy Stenzel retires after almost six years as head of diagnostic devices.
FDA publishes a guidance on enhanced drug distribution security at the package level.
FDA sends Satsuma Pharmaceuticals a complete response letter on its NDA for STS101 (dihydroergotamine nasal powder), an investigational product for th...